Insight Molecular Diagnostics (IMDX) Long-Term Deferred Tax (2018 - 2019)
Insight Molecular Diagnostics (IMDX) posted Long-Term Deferred Tax of $3.8 million for Q4 2019, down 43.51% sequentially from $6.8 million in Q4 2018, and down 43.51% YoY from $6.8 million in Q4 2018.
Insight Molecular Diagnostics (IMDX) Long-Term Deferred Tax (2018 - 2019) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 2 years of Long-Term Deferred Tax data on file, last reported at $3.8 million in Q4 2019.
- Quarterly Long-Term Deferred Tax fell 43.51% year-over-year to $3.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $3.8 million (down 43.51% YoY) and the FY2019 annual result came in at $3.8 million, down 43.51% from the prior year.
- Long-Term Deferred Tax slipped to $3.8 million in Q4 2019 per IMDX's latest filing, from $6.8 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $6.8 million in Q4 2018, with the low at $3.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.84 Mn |
| Dec 31, 2018 | 6.80 Mn |